Allopurinol (oral): Difference between revisions
Drake700263 (talk | contribs) mNo edit summary |
m Reverted edits by Drake700263 (Talk) to last version by Swilliams |
||
Line 9: | Line 9: | ||
<br> | <br> | ||
<font size="4"> | <font size="4"> | ||
[ | [[{{PAGENAME}}#FDA Package Insert Resources|FDA Package Insert Resources]] | ||
<br></font size><small>Indications, Contraindications, Side Effects, Drug Interactions, etc.</small><font size="4"><br> | <br></font size><small>Indications, Contraindications, Side Effects, Drug Interactions, etc.</small><font size="4"><br> | ||
<br> | <br> | ||
[http:// | [http://www.pace-med-apps.com/gfrcalc.htm Calculate Creatine Clearance] | ||
<br></font size><small>On line calculator of your patients Cr Cl by a variety of formulas.</small><font size="4"><br> | <br></font size><small>On line calculator of your patients Cr Cl by a variety of formulas.</small><font size="4"><br> | ||
<br> | <br> | ||
[http:// | [http://home.earthlink.net/~sensei11/convert.htm Convert pounds to Kilograms] | ||
<br></font size><small>On line calculator of your patients weight in pounds to Kg for dosing estimates.</small><font size="4"><br> | <br></font size><small>On line calculator of your patients weight in pounds to Kg for dosing estimates.</small><font size="4"><br> | ||
<br> [ | <br> [[{{PAGENAME}}#Publication Resources|Publication Resources]] | ||
<br></font size><small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4"><br> | <br></font size><small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#Trial Resources|Trial Resources]] | ||
<br></font size><small>Ongoing Trials, Trial Results</small><font size="4"><br> | <br></font size><small>Ongoing Trials, Trial Results</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#Guidelines & Evidence Based Medicine Resources|Guidelines & Evidence Based Medicine Resources]] | ||
<br></font size><small>US National Guidelines, Cochrane Collaboration, etc.</small><font size="4"><br> | <br></font size><small>US National Guidelines, Cochrane Collaboration, etc.</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#Media Resources|Media Resources]] | ||
<br></font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4"><br><br> | <br></font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4"><br><br> | ||
[ | [[{{PAGENAME}}#Patient Resources|Patient Resources]] | ||
<br></font size><small>Discussion Groups, Handouts, Blogs, News, etc.</small><font size="4"><br> | <br></font size><small>Discussion Groups, Handouts, Blogs, News, etc.</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#International Resources|International Resources]] | ||
<br></font size><small>en Español</small><font size="4"><br> | <br></font size><small>en Español</small><font size="4"><br> | ||
<br> | <br> | ||
Line 41: | Line 41: | ||
==FDA Package Insert Resources== | ==FDA Package Insert Resources== | ||
[ | [[{{PAGENAME}} indications|Indications]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} contraindications|Contraindications]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} side effects|Side Effects]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} drug interactions|Drug Interactions]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} precautions|Precautions]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} overdose|Overdose]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} instructions for administration|Instructions for Administration]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} how supplied|How Supplied]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} pharmacokinetics and molecular data|Pharmacokinetics and Molecular Data]] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Publication Resources== | ==Publication Resources== | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most Recent Articles on {{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review Articles on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28%28N+Engl+J+Med%5Bta%5D%29+OR+%28Lancet%5Bta%5D%29+OR+%28BMJ%5Bta%5D%29%29 Articles on {{PAGENAME}} in N Eng J Med, Lancet, BMJ] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} detailed information|WikiDoc State of the Art Review]] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://books.google.com/books?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=gp Textbook Information on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Trial Resources== | ==Trial Resources== | ||
[http:// | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials with {{PAGENAME}} at Clinical Trials.gov] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28randomized+controlled+trial%5BPublication+Type%5D+OR+%28randomized%5BTitle%2FAbstract%5D+AND+controlled%5BTitle%2FAbstract%5D+AND+trial%5BTitle%2FAbstract%5D%29%29 Trial Results with {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Guidelines & Evidence Based Medicine Resources== | ==Guidelines & Evidence Based Medicine Resources== | ||
[http:// | [http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cochrane Database Syst Rev[ta])}} Cochrane Collaboration on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cost effectiveness)}} Cost Effectiveness of {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Media Resources== | ==Media Resources== | ||
[http:// | [http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint Slides on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images of {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=hPo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+podcasts+OR+MP3&btnG=Search Podcasts & MP3s on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://video.google.com/videosearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&um=1&sa=N&tab=fv# Videos on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Patient Resources== | ==Patient Resources== | ||
[ | [[{{PAGENAME}} (patient information)|Patient Information from National Library of Medicine]] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.google.com/search?hl=en&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:for_patients&cx=disease_for_patients&sa=N&oi=cooptsr&resnum=0&ct=col3&cd=1 Patient Resources on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://groups.google.com/groups/search?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search Discussion Groups on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:patient_handouts&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col1&cd=3 Patient Handouts on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the News] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://finance.google.com/finance?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=te {{PAGENAME}} in the Marketplace] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==International Resources== | ==International Resources== | ||
[http:// | [http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+en+espanol&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a {{PAGENAME}} en Español] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> |
Revision as of 23:06, 22 January 2011
Synonyms / Brand Names: Allopurinolum, Allopurinol Sodium, Alopurinol, 7HP, Adenock, Ailural, Allo-Puren, Allopur, Allozym, Allural, Aloprim, Aloral, Alositol, Aluline, Anoprolin, Anzief, Apo-Allopurinol, Apulonga, Apurin, Apurol, Atisuril, Bleminol, Bloxanth, Caplenal, Cellidrin, Cosuric, Dabrosin, Dabroson, Dura Al, Embarin, Epidropal, Epuric, Foligan, Geapur, Gichtex, Gotax, HPP, Hamarin, Hexanuret, Ketanrift, Ketobun-A, Ledopur, Lopurin, Lysuron, Milurit, Miniplanor, Monarch, Nektrohan, Progout, Purinol, Remid, Riball, Sigapurol, Suspendol, Takanarumin, Urbol, Uricemil, Uriprim, Uripurinol, Uritas, Urobenyl, Urolit, Urosin, Urtias, Urtias 100, Xanturat, Zyloprim, Zyloric, Allohexal
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
The dosage of Allopurinol to accomplish full control of gout and to lower serum uric acid to normal or near-normal levels varies with the severity of the disease. The average is 200 to 300 mg per day for patients with mild gout and 400 to 600 mg per day for those with moderately severe tophaceous gout. The appropriate dosage may be administered in divided doses or as a single equivalent dose with the 300 mg tablet. Dosage requirements in excess of 300 mg should be administered in divided doses. The minimal effective dosage is 100 to 200 mg daily and the maximal recommended dosage is 800 mg daily. To reduce the possibility of flare-up of acute gouty attacks, it is recommended that the patient start with a low dose of Allopurinol (100 mg daily) and increase at weekly intervals by 100 mg until a serum uric acid level of 6 mg/dL or less is attained but without exceeding the maximal recommended dosage.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA on Allopurinol (oral)
Return to top
Publication Resources
Most Recent Articles on Allopurinol (oral)
Review Articles on Allopurinol (oral)
Articles on Allopurinol (oral) in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Allopurinol (oral)
Return to top
Trial Resources
Ongoing Trials with Allopurinol (oral) at Clinical Trials.gov
Trial Results with Allopurinol (oral)
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Allopurinol (oral)
Cochrane Collaboration on Allopurinol (oral)
Cost Effectiveness of Allopurinol (oral)
Return to top
Media Resources
Powerpoint Slides on Allopurinol (oral)
Images of Allopurinol (oral)
Podcasts & MP3s on Allopurinol (oral)
Videos on Allopurinol (oral)
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Allopurinol (oral)
Discussion Groups on Allopurinol (oral)
Patient Handouts on Allopurinol (oral)
Blogs on Allopurinol (oral)
Allopurinol (oral) in the News
Allopurinol (oral) in the Marketplace
Return to top
International Resources
Allopurinol (oral) en Español
Return to top
Adapted from the FDA Package Insert.